Skip to main content

Campylobacter seroconversion rates in selected countries in the European Union

  • P. F. M. TEUNIS (a1) (a2), G. FALKENHORST (a3), C. W. ANG (a4), M. A. STRID (a3), H. DE VALK (a5), M. SADKOWSKA-TODYS (a6), L. ZOTA (a7), M. KUUSI (a8), M. C. ROTA (a9), J. B. SIMONSEN (a3), K. MØLBAK (a3), Y. T. H. P. VAN DUYNHOVEN (a1) and W. VAN PELT (a1)...

As a major foodborne pathogen, Campylobacter is frequently isolated from food sources of animal origin. In contrast, human Campylobacter illness is relatively rare, but has a considerable health burden due to acute enteric illness as well as severe sequelae. To study silent transmission, serum antibodies can be used as biomarkers to estimate seroconversion rates, as a proxy for infection pressure. This novel approach to serology shows that infections are much more common than disease, possibly because most infections remain asymptomatic. This study used antibody titres measured in serum samples collected from healthy subjects selected randomly in the general population from several countries in the European Union (EU). Estimates of seroconversion rates to Campylobacter were calculated for seven countries: Romania, Poland, Italy, France, Finland, Denmark and The Netherlands. Results indicate high infection pressures in all these countries, slightly increasing in Eastern EU countries. Of these countries, the differences in rates of notified illnesses are much greater, with low numbers in France and Poland, possibly indicating lower probability of detection due to differences in the notification systems, but in the latter case it cannot be excluded that more frequent exposure confers better protection due to acquired immunity.

Corresponding author
*Author for correspondence: P. F. M. Teunis, Ph.D., National Institute of Public Health and the Environment, Centre for Infectious Disease Control, Anthonie van Leeuwenhoeklaan 9, 3721MA Bilthoven, The Netherlands. (Email:
Hide All
1.Ruiz-Palacios GM. The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken [Editorial commentary]. Clinical Infectious Diseases 2007; 44: 701703.
2.Kubota K, et al. Estimating the burden of acute gastroenteritis and foodborne illness caused by Campylobacter, Salmonella, and Vibrio parahaemolyticus by using population-based telephone survey data, Miyagi Prefecture, Japan, 2005 to 2006. Journal of Food Protection 2011; 74: 15921598.
3.Havelaar AH, et al. Disease burden of foodborne pathogens in the Netherlands, 2009. International Journal of Food Microbiology 2012a; 156: 231238.
4.EFSA. The community summary report on trends and sources of zoonoses and zoonotic agents in the European Union in 2007. EFSA Journal 2009; 223: 1320.
5.Endtz HP, et al. Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes. Journal of Clinical Microbiology 2000; 38: 22972301.
6.Ang CW, Jacobs BC, Laman JD. The Guillain-Barré syndrome: a true case of molecular mimicry. Trends in Immunology 2004; 25: 6166.
7.Tam CC, et al. Guillain–Barré syndrome and preceding infection with Campylobacter, influenza and Epstein– Barr virus in the general practice research database. PLoS ONE 2007; 2: e344. Wit MAS, et al. Sensor, a population-based cohort study on gastroenteritis in the Netherlands: incidence and etiology. American Journal of Epidemiology 2001; 154: 666674.
9.Amar CFL, et al. Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993–1996). European Journal of Clinical Microbiology and Infectious Diseases 2007; 26: 311323.
10.Madden RH, Moran L, Scates P. Frequency of occurrence of Campylobacter spp. in red meats and poultry in Northern Ireland and their subsequent subtyping using polymerase chain reaction-restriction fragment length polymorphism and the random amplified polymorphic DNA method. Journal of Applied Microbiology 1998; 84: 703708.
11.Altekruse SF, et al. Campylobacter jejuni – an emerging foodborne pathogen. Emerging Infectious Diseases 1999; 5: 2835.
12.Devane ML, et al. The occurrence of Campylobacter subtypes in environmental reservoirs and potential transmission routes. Journal of Applied Microbiology 2005; 98: 980990.
13.Nauta MJ, et al. Risk assessment of Campylobacter in the Netherlands via broiler meat and other routes. Technical Report 250 911 006, RIVM, Bilthoven, 2005 (
14.Teunis P, et al. A reconsideration of the Campylobacter dose-response relation. Epidemiology and Infection 2005; 133: 583592.
15.Strid MA, et al. Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2 year follow-up study of 210 patients. Clinical and Diagnostic Laboratory Immunology 2001; 8: 314319.
16.Ang CW, et al. Validation of an ELISA for the diagnosis of recent Campylobacter infections in Guillain-Barré and reactive arthritis patients. Clinical Microbiology and Infection 2007; 13: 915922.
17.Ang CW, et al. Seroepidemiological studies indicate frequent and repeated exposure to Campylobacter spp. during childhood. Epidemiology and Infection 2011; 139: 13611368.
18.Falkenhorst G, et al. Serological cross-sectional studies on Salmonella incidence in eight European countries: no correlation with incidence of reported cases. BMC Public Health 2012; 12: 523523.
19.Versteegh FGA, et al. Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiology and Infection 2005; 133: 737748.
20.Simonsen J, et al. Estimation of incidences of infectious diseases based on antibody measurements. Statistics in Medicine 2009; 28: 18821895.
21.Teunis PFM, et al. Kinetics of IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiology and Infection 2002; 129: 479489.
22.Teunis PFM, et al. Biomarker dynamics: estimating infection rates from serological data. Statistics in Medicine 2012; 31: 22402248.
23.Doorduyn Y, et al. Risk factors for indigenous Campylobacter jejuni and Campylobacter coli infections in the Netherlands: a case-control study. Epidemiology and Infection 2010; 138: 13911404.
24.Scallan E. Activities, achievements, and lessons learned during the first 10 years of the Foodborne Diseases Active Surveillance Network: 1996–2005. Clinical Infectious Diseases 2007; 44: 718725.
25.Black RE, et al. Experimental Campylobacter jejuni infection in humans. Journal of Infectious Diseases 1988; 157: 472479.
26.Hellard ME, et al. Prevalence of enteric pathogens among community based asymptomatic individuals. Journal of Gastroenterology and Hepatology 2000; 15: 290293.
27.Ekdahl K, Giesecke J. Travellers returing to Sweden as sentinels for comparative disease incidence in other European countries, Campylobacter and Giardia as examples. Eurosurveillance 2004; 9: 19.
28.Havelaar AH, et al. Estimating the true incidence of campylobacteriosis and salmonellosis in the European Union, 2009. Epidemiology and Infection. Published online:13 04 2012. doi:10.1017/S0950268812000568.
29.Swart AN, et al. The protective effects of temporary immunity under imposed infection pressure. Epidemics 2012; 4: 4347.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 8
Total number of PDF views: 26 *
Loading metrics...

Abstract views

Total abstract views: 154 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 24th November 2017. This data will be updated every 24 hours.